Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 48,877 | 41,603 | 49,028 | 68,414 | 53,218 |
| Operating Income | -48,877 | -41,603 | -49,028 | -68,414 | -53,218 |
| Interest Expense | 2,345 | 2,202 | 1,922 | 1,653 | 1,500 |
| Other Income | 1,185 | -32 | -3,066 | 5,384 | 300 |
| Pre-tax Income | -50,037 | -43,837 | -54,016 | -64,683 | -54,418 |
| Income Tax | 677 | -664 | -141 | -22 | 80 |
| Net Income Continuous | -50,714 | -43,173 | -53,875 | -64,661 | -54,498 |
| Net Income | $-50,714 | $-43,173 | $-53,875 | $-64,661 | $-54,498 |
| EPS Basic Total Ops | -0.53 | -0.45 | -0.57 | -0.69 | -0.60 |
| EPS Basic Continuous Ops | -0.53 | -0.45 | -0.57 | -0.69 | -0.60 |
| EPS Diluted Total Ops | -0.53 | -0.45 | -0.57 | -0.69 | -0.60 |
| EPS Diluted Continuous Ops | -0.53 | -0.45 | -0.57 | -0.69 | -0.60 |
| EBITDA(a) | $-48,788 | $-41,567 | $-48,993 | $-68,382 | $-53,190 |